Delivery Order SPE2DB20D2104-SPE2DB23FV44F
Award Date 9/20/23
Potential Completion Date 9/21/23
Potential Value $9.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price of $12,459.22 for the supply of XARELTO 20 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of XARELTO 20 MG TABLET 90S. The contract, valued at $5,766.49, is a Firm Fixed Price Delivery Order with an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, specifically XARELTO 20 MG TABLET 90S. The contract, valued at $9,155.07, is a Firm Fixed Price Delivery Order that will run through September 28, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract...
- This federal contract award was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $10,403.96, is a delivery order contract for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of December 8, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,712.39 firm-fixed-price delivery order is for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 16, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $8,613.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for 4562842369 - XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through November 17, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $14,970.96, is a delivery order for the supply of XARELTO 20 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2024 and is a firm fixed-price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $22,644.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product XARELTO 20 MG TABLET 90S, with a performance period ending on February 29, 2024. The contract is a firm-fixed-price arrangement and was awarded through full and open competition, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,371.03 firm fixed-price delivery order is for the supply of the prescription medication XARELTO 20 MG TABLET 90S. The contract has an ultimate completion date of February 1, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award, valued at $1,588.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of XARELTO 15 MG TABLET 30S, a pharmaceutical product. The award has a completion date of July 19, 2022 and was made under a Firm Fixed Price contract type. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in...